综述 Review

抗菌肽与革兰氏阳性菌的互作及其机制

展开
  • 1. 陕西科技大学食品与生物工程学院, 西安 710021;
    2. 西安市微生物药物工程实验室, 西安 710021
魏媛(1994—),女,河南新乡人,硕士研究生,从事微生物工程研究。E-mail:1057543933@qq.com

收稿日期: 2017-02-01

  网络出版日期: 2017-08-02

Interreaction and Its Mechanism between Peptides and Gram-Positive Bacteria

Expand
  • 1. College of Food and Biological Engineering College, Shanxi University of Science & Technology, Xi'an 710021, China;
    2. Xi'an Microbial Drug Engineering Laboratory, Xi'an 710021, China

Received date: 2017-02-01

  Online published: 2017-08-02

摘要

抗菌肽(AMP)因其具有理化性质稳定、抗菌谱广、耐高温以及不易使靶菌株产生耐药性等特点,作为一种新型的抗菌剂被提出,有望成为饲料抗生素的理想替代品,具有广阔的应用前景。但是随着对AMP的深入研究,发现部分细菌能对AMP产生耐药性。目前,还没有对AMP对革兰氏阳性(G+)菌芽孢的抗性机制进行深入的研究。AMP对G+菌的抑菌机制还知之甚少。在本文中,我们对AMP对G+菌的作用靶点、抑菌机制以及G+菌对AMP产生的耐药性等方面进行了综述。

本文引用格式

魏媛, 龚国利 . 抗菌肽与革兰氏阳性菌的互作及其机制[J]. 动物营养学报, 2017 , 29(8) : 2636 -2642 . DOI: 10.3969/j.issn.1006-267x.2017.08.004

Abstract

Antimicrobial peptides (AMP) have been used as a new type of antibacterial agent because of their stable physical and chemical properties, wide antibacterial spectrum, high-temperature resistance. Besides, possibilities of resistance that bacteria might develop toward AMP are much lower than other antibiotics. These characteristics make AMP become the ideal substitute for antibiotics, and thus make AMP having a broad application prospect. However, with the in-depth study of AMP, we found that some microbes can still produce resistance to AMP. At present, there is no in-depth study on the mechanism of gram-positive spores's resistance toward AMP. In addition, little is known about the antibacterial mechanism of AMP to gram-positive bacteria. This review summarized researches on the target of AMP, its antibacterial mechanism against gram-positive and the antibiotic resistance of gram-positive strains.

参考文献

[1] LEWIS K.Platforms for antibiotic discovery[J].Nature Reviews Drug Discovery,2013,12(5):371-387.  

[2] FOX J L.Antimicrobial peptides stage a comeback[J].Nature Biotechnology,2013,31(5):379-382.  

[3] WILMES M,STOCKEM M,BIERBAUM G,et al.Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes[J].Antibiotics (Basel),2014,3(4):617-631.  

[4] NGUYEN L T,HANEY E F,VOGEL H J.The expanding scope of antimicrobial peptide structures and their modes of action[J].Trends in Biotechnology,2011,29(9):464-472.  

[5] TEIXEIRA V,FEIO M J,BASTOS M.Role of lipids in the interaction of antimicrobial peptides with membranes[J].Progress in Lipid Research,2012,51(2):149-177.  

[6] WIMLEY W C.Describing the mechanism of antimicrobial peptide action with the interfacial activity model[J].ACS Chemical Biology,2010,5(10):905-917.  

[7] GRAY A N,EGAN A J F,VAN'T VEER I L,et al.Coordination of peptidoglycan synthesis and outer membrane constriction during Escherichia coli cell division[J].eLife Sciences,2015,4:e07118.

[8] NEUHAUS F C,BADDILEY J.A continuum of anionic charge:structures and functions of D-alanyl-teichoic acids in gram-positive bacteria[J].Microbiology and Molecular Biology Reviews,2003,67(4):686-723.  

[9] SCHNEIDER T,KRUSE T,WIMMER R,et al.Plectasin,a fungal defensin,targets the bacterial cell wall precursor lipid Ⅱ[J].Science,2010,328(5982):1168-1172.  

[10] HASPER H E,KRAMER N E,SMITH J L,et al.An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid Ⅱ[J].Science,2006,313(5793):1635-1637.

[11] SASS V,SCHNEIDER T,WILMES M,et al.Human β-defensin 3 inhibits cell wall biosynthesis in staphylococci[J].Infection and Immunity,2010,78(6):2793-2800.  

[12] DE LEEUW E,LI C Q,ZENG P Y,et al.Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid Ⅱ[J].FEBS Letters,2010,584(8):1543-1548.  

[13] LEE H,HWANG J S,LEE J,et al.Scolopendin 2,a cationic antimicrobial peptide from centipede,and its membrane-active mechanism[J].Biochimica et Biophysica Acta (BBA):Biomembranes,2015,1848(2):634-642.  

[14] WANG K R,DANG W,YAN J X,et al.Membrane perturbation action mode and structure-activity relationships of Protonectin,a novel antimicrobial peptide from the venom of the neotropical social wasp Agelaia pallipes pallipes[J].Antimicrobial Agents and Chemotherapy,2013,57(10):4632-4639.  

[15] BARNS K J,WEISSHAAR J C.Real-time attack of LL-37 on single Bacillus subtilis cells[J].Biochimica et Biophysica Acta:Biomembranes,2013,1828(6):1511-1520.  

[16] RANGARAJAN N,BAKSHI S,WEISSHAAR J C.Localized permeabilization of E. coli membranes by the antimicrobial peptide Cecropin A[J].Biochemistry,2013,52(38):6584-6594.

[17] MILEYKOVSKAYA E,DOWHAN W.Cardiolipin membrane domains in prokaryotes and eukaryotes[J].Biochimica et Biophysica Acta:Biomembranes,2009,1788(10):2084-2091.  

[18] LUTKENHAUS J,PICHOFF S,DU S S.Bacterial cytokinesis:from Z ring to divisome [J].Cytoskeleton,2012,69(10):778-790.  

[19] POGLIANO J,POGLIANO N,SILVERMAN J A.Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins[J].Journal of Bacteriology,2012,194(17):4494-4504.  

[20] WENZEL M,CHIRIAC A I,OTTO A,et al.Small cationic antimicrobial peptides delocalize peripheral membrane proteins[J].Proceedings of the National Academy of Sciences of the United States of America,2014,111(14):E1409-E1418.  

[21] GHOSH A,KAR R K,JANA J,et al.Indolicidin targets duplex DNA:structural and mechanistic insight through a combination of spectroscopy and microscopy[J].ChemMedChem,2014,9(9):2052-2058.  

[22] DANGEL A,ACKERMANN N,ABDEL-HADI O,et al.A de novo-designed antimicrobial peptide with activity against multiresistant Staphylococcus aureus acting on RsbW kinase[J].The FASEB Journal,2013,27(11):4476-4488.  

[23] SETLOW P.Germination of spores of Bacillus species:what we know and do not know[J].Journal of Bacteriology,2014,196(7):1297-1305.  

[24] GUT I M,BLANKE S R,VAN DER DONK W A.Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin[J].ACS Chemical Biology,2011,6(7):744-752.  

[25] YANG S J,NAST C C,MISHRA N N,et al.Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus:evidence for multiple resistance mechanisms[J].Antimicrobial Agents and Chemotherapy,2010,54(8):3079-3085.  

[26] BAYER A S,MISHRA N N,SAKOULAS G,et al.Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates:role in cross-resistance between daptomycin and host defense antimicrobial peptides[J].Antimicrobial Agents and Chemotherapy,2014,58(12):7462-7467.  

[27] CUI LZ,MURAKAMI H,KUWAHARA-ARAI K,et al.Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50[J].Antimicrobial Agents and Chemotherapy,2000,44(9):2276-2285.  

[28] CUI L Z,MA X X,SATO K,et al.Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus[J].Journal of Clinical Microbiology,2003,41(1):5-14.  

[29] MISHRA N N,BAYER A S,TRAN T T,et al.Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content[J].PLoS One,2012,7(8):e43958.  

[30] MISHRA N N,BAYER A S.Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus[J].Antimicrobial Agents and Chemotherapy,2013,57(2):1082-1085.  

[31] MCBRIDE S M,SONENSHEIN A L.The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile[J].Microbiology,2011,157(5):1457-1465.  

[32] ROSE W E,FALLON M,MORAN J J M,et al.Vancomycin tolerance in methicillin-resistant Staphylococcus aureus:influence of vancomycin,daptomycin,and telavancin on differential resistance gene expression[J].Antimicrobial Agents and Chemotherapy,2012,56(8):4422-4427.  

[33] PELEG A Y,MIYAKIS S,WARD D V,et al.Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus[J].PLoS One,2012,7(1):e28316.  

[34] COX E,MICHALAK A,PAGENTINE S,et al.Lysylated phospholipids stabilize models of bacterial lipid bilayers and protect against antimicrobial peptides[J].Biochimica et Biophysica Acta:Biomembranes,2014,1838(9):2198-2204.  

[35] PESCHEL A,SAHL H G.The co-evolution of host cationic antimicrobial peptides and microbial resistance[J].Nature Reviews Microbiology,2006,4(7):529-536.  

[36] JORDAN S,HUTCHINGS M I,MASCHER T.Cell envelope stress response in Gram-positive bacteria[J].FEMS Microbiology Reviews,2008,32(1):107-146.  

[37] KINGSTON A W,SUBRAMANIAN C,ROCK C O,et al.A σW-dependent stress response in Bacillus subtilis that reduces membrane fluidity[J].Molecular Microbiology,2011,81(1):69-79.  

[38] PIETIÄINEN M,GARDEMEISTER M,MECKLIN M,et al.Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems[J].Microbiology,2005,151(5):1577-1592.  

[39] EIAMPHUNGPORN W,HELMANN J D.The Bacillus subtilis σM regulon and its contribution to cell envelope stress responses[J].Molecular Microbiology,2008,67(4):830-848.  

[40] CAO M,HELMANN J D.The Bacillus subtilis extracytoplasmic-function σX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides[J].Journal of Bacteriology,2004,186(4):1136-1146.  

[41] OHKI R,GIYANTO,TATENO K,et al.The BceRS two-component regulatory system induces expression of the bacitracin transporter,BceAB,in Bacillus subtilis[J].Molecular Microbiology,2003,49(4):1135-1144.  

[42] STARO N' A,FINKEISON D E,Mascher T.Peptide antibiotic sensing and detoxification modules of Bacillus subtilis[J].Antimicrobial Agents and Chemotherapy,2011,55(2):515-525.  

[43] LI M,LAI Y P,VILLARUZ A E,et al.Gram-positive three-component antimicrobial peptide-sensing system[J].Proceedings of the National Academy of Sciences of the United States of America,2007,104(22):9469-9474.  

[44] YANG S J,BAYER A S,MISHRA N N,et al.The Staphylococcus aureus two-component regulatory system,GraRS,senses and confers resistance to selected cationic antimicrobial peptides [J].Infection and Immunity,2012,80(1):74-81.  

[45] GRUENHEID S,LE MOUAL H.Resistance to antimicrobial peptides in Gram-negative bacteria[J].FEMS Microbiology Letters,2012,330(2):81-89.  
文章导航

/